$KNSA
Kiniksa Pharmaceuticals Ltd

2022 Q3 Form 10-Q Financial Statement

#000155837022016250 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $99.14M $12.10M
YoY Change 719.64%
Cost Of Revenue $6.937M $2.767M
YoY Change 150.7%
Gross Profit $92.20M $9.328M
YoY Change 888.4%
Gross Profit Margin 93.0% 77.12%
Selling, General & Admin $24.68M $20.76M
YoY Change 18.87% 75.94%
% of Gross Profit 26.77% 222.55%
Research & Development $16.49M $19.24M
YoY Change -14.3% -38.78%
% of Gross Profit 17.88% 206.22%
Depreciation & Amortization $177.0K $373.0K
YoY Change -52.55% -42.53%
% of Gross Profit 0.19% 4.0%
Operating Expenses $41.16M $40.00M
YoY Change 2.92% -7.46%
Operating Profit $46.41M -$30.67M
YoY Change -251.35% -29.04%
Interest Expense $322.0K $5.000K
YoY Change 6340.0% -90.0%
% of Operating Profit 0.69%
Other Income/Expense, Net
YoY Change
Pretax Income $46.74M -$30.66M
YoY Change -252.42% -28.97%
Income Tax -$177.4M -$118.0K
% Of Pretax Income -379.5%
Net Earnings $224.1M -$30.54M
YoY Change -833.67% -30.32%
Net Earnings / Revenue 226.05% -252.53%
Basic Earnings Per Share $3.23 -$0.44
Diluted Earnings Per Share $3.18 -$444.8K
COMMON SHARES
Basic Shares Outstanding 69.45M 68.66M
Diluted Shares Outstanding 70.55M 68.66M

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.7M $200.2M
YoY Change 0.27% -45.07%
Cash & Equivalents $175.8M $190.2M
Short-Term Investments $24.96M $10.00M
Other Short-Term Assets $15.31M $8.499M
YoY Change 80.15% -39.29%
Inventory $14.62M $5.606M
Prepaid Expenses
Receivables $11.16M $3.224M
Other Receivables $0.00 $0.00
Total Short-Term Assets $241.8M $217.5M
YoY Change 11.17% -42.52%
LONG-TERM ASSETS
Property, Plant & Equipment $1.995M $3.168M
YoY Change -37.03% -30.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.627M $6.551M
YoY Change -14.1% 13547.92%
Total Long-Term Assets $218.1M $35.35M
YoY Change 517.13% 489.12%
TOTAL ASSETS
Total Short-Term Assets $241.8M $217.5M
Total Long-Term Assets $218.1M $35.35M
Total Assets $460.0M $252.9M
YoY Change 81.9% -34.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.469M $1.649M
YoY Change -10.92% -57.99%
Accrued Expenses $30.87M $28.53M
YoY Change 8.2% 46.49%
Deferred Revenue $12.09M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $56.49M $34.43M
YoY Change 64.09% 38.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.820M $885.0K
YoY Change 105.65% -7.52%
Total Long-Term Liabilities $1.820M $885.0K
YoY Change 105.65% -7.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.49M $34.43M
Total Long-Term Liabilities $1.820M $885.0K
Total Liabilities $75.95M $38.81M
YoY Change 95.68% 49.83%
SHAREHOLDERS EQUITY
Retained Earnings -$496.5M -$639.1M
YoY Change -22.31% 37.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $384.0M $214.0M
YoY Change
Total Liabilities & Shareholders Equity $460.0M $252.9M
YoY Change 81.9% -34.22%

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $224.1M -$30.54M
YoY Change -833.67% -30.32%
Depreciation, Depletion And Amortization $177.0K $373.0K
YoY Change -52.55% -42.53%
Cash From Operating Activities $62.05M -$28.51M
YoY Change -317.66% -16.93%
INVESTING ACTIVITIES
Capital Expenditures -$22.00K -$51.00K
YoY Change -56.86% 410.0%
Acquisitions
YoY Change
Other Investing Activities $19.06M $47.90M
YoY Change -60.2% -132.01%
Cash From Investing Activities $19.04M $47.85M
YoY Change -60.21% -131.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 361.0K 2.680M
YoY Change -86.53% -98.17%
NET CHANGE
Cash From Operating Activities 62.05M -28.51M
Cash From Investing Activities 19.04M 47.85M
Cash From Financing Activities 361.0K 2.680M
Net Change In Cash 81.45M 22.02M
YoY Change 269.91% -158.58%
FREE CASH FLOW
Cash From Operating Activities $62.05M -$28.51M
Capital Expenditures -$22.00K -$51.00K
Free Cash Flow $62.08M -$28.46M
YoY Change -318.13% -17.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1327726
dei Entity Address Address Line1
EntityAddressAddressLine1
Clarendon House
dei Entity Address Address Line2
EntityAddressAddressLine2
2 Church Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Hamilton
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
HM11
dei Entity Address Country
EntityAddressCountry
BM
dei City Area Code
CityAreaCode
808
dei Local Phone Number
LocalPhoneNumber
451-3453
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1800000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1687000
us-gaap Share Based Compensation
ShareBasedCompensation
18748000
us-gaap Share Based Compensation
ShareBasedCompensation
19042000
knsa Noncash Lease Expense
NoncashLeaseExpense
2253000
knsa Noncash Lease Expense
NoncashLeaseExpense
1895000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-121000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-617000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-185843000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8726000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1034000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7174000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3224000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10946000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5606000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2919000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1059000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-399000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1116000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
82000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2834000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6173000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5550000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5627000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8720000
knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
140304000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
322000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
us-gaap Investment Income Interest
InvestmentIncomeInterest
459000
us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17383000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-107414000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
81000
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 knsa Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2021Q4 knsa Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
dei Entity Central Index Key
EntityCentralIndexKey
0001730430
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38492
dei Entity Registrant Name
EntityRegistrantName
Kiniksa Pharmaceuticals, Ltd.
dei Security12b Title
Security12bTitle
Class A Common Shares
dei Trading Symbol
TradingSymbol
KNSA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175761000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
73062000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
97460000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
107700000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
296300000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34582000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
178676000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2127000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4673000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
801000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1326000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4673000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
53291000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
75935000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
579000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
370000
CY2021Q4 us-gaap Liabilities
Liabilities
47763000
us-gaap Net Income Loss
NetIncomeLoss
178902000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
880554000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
860482000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
241815000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122470000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
24963000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
270000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
59731000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11159000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3985000
CY2022Q3 us-gaap Inventory Net
InventoryNet
14621000
CY2022Q3 us-gaap Liabilities
Liabilities
75945000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3675000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15311000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6585000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68444061
CY2021Q4 us-gaap Assets Current
AssetsCurrent
196446000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1995000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
46413000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30667000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19250000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
185843000
CY2022Q3 us-gaap Assets
Assets
459953000
CY2021Q4 us-gaap Assets
Assets
232800000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1469000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1868000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30868000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38031000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12092000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3274000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3381000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8789000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1544000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
56492000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44824000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14198000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3435000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2669000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1820000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-496495000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-675397000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
384008000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185037000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
459953000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
232800000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99135000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12095000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
158296000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19799000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16485000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19236000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51100000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71864000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24677000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20759000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70736000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63207000
CY2022Q3 knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
52722000
CY2021Q3 knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
42762000
knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
154570000
us-gaap Operating Income Loss
OperatingIncomeLoss
3726000
us-gaap Operating Income Loss
OperatingIncomeLoss
-120505000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
224093000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
166244000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46735000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30662000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4185000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-120485000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-177358000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-174717000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1106000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
224093000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
us-gaap Net Income Loss
NetIncomeLoss
178902000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.23
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.78
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69445071
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68662673
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69305755
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68444061
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70552018
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68662673
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70286444
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
us-gaap Net Income Loss
NetIncomeLoss
178902000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-72000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
224113000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30616000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
178898000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-121602000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185037000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
423000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6031000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-37000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25210000
us-gaap Profit Loss
ProfitLoss
178902000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
542000
us-gaap Profit Loss
ProfitLoss
-121591000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
295000
knsa Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2217000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6676000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19981000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
153494000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
360000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6041000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
224093000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
384008000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
311935000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
1106000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7126000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-49484000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
270696000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
887000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5717000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-41563000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
235785000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2680000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6199000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
214048000
knsa Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1700000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
26290000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1550000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
80000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122470000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114248000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30868000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38031000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175761000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190183000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4608000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
859000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2876000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1462000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 36pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the recognition of revenue, the capitalization of inventory, the accrual for research and development expenses, the valuation of share-based awards and the realizability of deferred tax assets. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p>
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-496495000
us-gaap Net Income Loss
NetIncomeLoss
178902000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17383000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
200724000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2022Q3 knsa Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2021Q4 knsa Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
knsa Number Of Securities Unrealized Loss Position
NumberOfSecuritiesUnrealizedLossPosition
6
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
22466000
CY2021 knsa Number Of Securities Unrealized Loss Position
NumberOfSecuritiesUnrealizedLossPosition
11
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
49739000
CY2021Q4 knsa Product Revenue Reserve For Contractual Adjustments
ProductRevenueReserveForContractualAdjustments
515000
CY2021Q4 knsa Product Revenue Reserve For Government Rebates
ProductRevenueReserveForGovernmentRebates
719000
CY2021Q4 knsa Product Revenue Reserve For Sales Returns
ProductRevenueReserveForSalesReturns
101000
CY2021Q4 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
1335000
knsa Product Revenue Provision For Contractual Adjustments
ProductRevenueProvisionForContractualAdjustments
4993000
knsa Product Revenue Provision For Government Rebates
ProductRevenueProvisionForGovernmentRebates
3011000
knsa Product Revenue Provision For Product Returns
ProductRevenueProvisionForProductReturns
227000
knsa Product Revenue Provision For Reserves And Allowances
ProductRevenueProvisionForReservesAndAllowances
8231000
knsa Product Revenue Refunds On Contractual Adjustments
ProductRevenueRefundsOnContractualAdjustments
3797000
knsa Product Revenue Refunds And Payments On Government Rebates
ProductRevenueRefundsAndPaymentsOnGovernmentRebates
1659000
knsa Product Revenue Refunds And Credits For Reserves And Allowances
ProductRevenueRefundsAndCreditsForReservesAndAllowances
5456000
knsa Product Revenue Contractual Adjustments Payments And Sales Returns Prior Year Sales
ProductRevenueContractualAdjustmentsPaymentsAndSalesReturnsPriorYearSales
295000
knsa Product Revenue Government Rebates Payments And Sales Returns Prior Year Sales
ProductRevenueGovernmentRebatesPaymentsAndSalesReturnsPriorYearSales
535000
knsa Product Revenue Refunds And Credits For Reserves And Allowances Prior Year Sales
ProductRevenueRefundsAndCreditsForReservesAndAllowancesPriorYearSales
830000
CY2022Q3 knsa Product Revenue Reserve For Contractual Adjustments
ProductRevenueReserveForContractualAdjustments
1416000
CY2022Q3 knsa Product Revenue Reserve For Government Rebates
ProductRevenueReserveForGovernmentRebates
1536000
CY2022Q3 knsa Product Revenue Reserve For Sales Returns
ProductRevenueReserveForSalesReturns
328000
CY2022Q3 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
3280000
CY2022Q3 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
3280000
CY2021Q4 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
1335000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8916000
CY2022Q3 knsa Accrued Collaboration Expenses Current
AccruedCollaborationExpensesCurrent
4660000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14621000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3675000
CY2022Q3 us-gaap Inventory Net
InventoryNet
14621000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3675000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8600000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8749000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6605000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5915000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1995000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2834000
CY2022Q3 us-gaap Depreciation
Depreciation
177000
CY2021Q3 us-gaap Depreciation
Depreciation
373000
us-gaap Depreciation
Depreciation
885000
us-gaap Depreciation
Depreciation
1079000
CY2021Q4 knsa Accrued Collaboration Expenses Current
AccruedCollaborationExpensesCurrent
835000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3754000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2933000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20000000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1500000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
750000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19250000
CY2022Q3 knsa Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
13559000
CY2021Q4 knsa Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
24977000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8316000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6041000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6199000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18748000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19042000
knsa Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
26290000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26290000
CY2017Q3 knsa Time Period To Terminate Agreement By Both Parties Under Uncured Material Breaches
TimePeriodToTerminateAgreementByBothPartiesUnderUncuredMaterialBreaches
P90D
CY2017Q3 knsa Time Period To Terminate Agreement Under Payment Related Breaches
TimePeriodToTerminateAgreementUnderPaymentRelatedBreaches
P30D
CY2017Q3 knsa Consecutive Suspension Of Activities Period To Terminate Agreement
ConsecutiveSuspensionOfActivitiesPeriodToTerminateAgreement
P12M
CY2017Q3 knsa Time Period To Terminate Agreement After Eighteen Months Of Agreement
TimePeriodToTerminateAgreementAfterEighteenMonthsOfAgreement
P1Y
CY2017Q3 knsa Time Period To Terminate Agreement If Products Are Determined To Have Certain Safety Concerns
TimePeriodToTerminateAgreementIfProductsAreDeterminedToHaveCertainSafetyConcerns
P3M
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
224093000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69445071
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68662673
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69305755
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68444061
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70552018
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68662673
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70286444
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68444061
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.23
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.78
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.78
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9310394
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10357635
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10427438
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10357635
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-177358000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-174717000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-185843000
CY2022Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
33019000

Files In Submission

Name View Source Status
0001558370-22-016250-index-headers.html Edgar Link pending
0001558370-22-016250-index.html Edgar Link pending
0001558370-22-016250.txt Edgar Link pending
0001558370-22-016250-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knsa-20220930.xsd Edgar Link pending
knsa-20220930x10q.htm Edgar Link pending
knsa-20220930xex10d1.htm Edgar Link pending
knsa-20220930xex10d1001.jpg Edgar Link pending
knsa-20220930xex10d2.htm Edgar Link pending
knsa-20220930xex10d3.htm Edgar Link pending
knsa-20220930xex10d3001.jpg Edgar Link pending
knsa-20220930xex31d1.htm Edgar Link pending
knsa-20220930xex31d2.htm Edgar Link pending
knsa-20220930xex32d1.htm Edgar Link pending
knsa-20220930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
knsa-20220930_cal.xml Edgar Link unprocessable
knsa-20220930_def.xml Edgar Link unprocessable
knsa-20220930_lab.xml Edgar Link unprocessable
knsa-20220930_pre.xml Edgar Link unprocessable
knsa-20220930x10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending